Advertisement

Topics

Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

11:20 EDT 20th September 2018 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 130,000+

Thursday 20th September 2018

AI tools are helping researchers to validate existing scientific hypotheses. And some can even suggest new hypotheses for guiding experiments. https://go.nature.com/2xhMhvd 

AI tools are helping researchers to validate existing scientific hypotheses. And some can even suggest new hypotheses for guiding experiments. https://go.nature.com/2xhMhvd 

Phesi files patent for clinical trial protocol development method, system

The clinical development services provider Phesi is looking to patent its method and system for developing clinical trial protocols â which enables faster patient enrollment and study completion, says CEO.

GeneOne signs licensing agreement for RNA development

VGXI, a subsidiary of GeneOne, signed a licensing agreement with Houston Methodist Research Institute to produce RNA one of the most valued clinical ingredients.

Grifols secures FTC’s conditional approval for Biotest US acquisition

Grifols is a global healthcare company based in Spain. Biotest US is a healthcare company based in Florida. According to the complaint, which was announced in August 2018, The post Grifols secures FTC’s conditional approval for Biotest US acquisition appeared first on Pharma Business review.

Pharma Technology Focus – Issue 75

Pharma Technology Focus is now available on all devices. Read it for free here. Researchers from the University of Toronto have...Read More... The post Pharma Technology Focus – Issue 75 appeared first on Pharmaceutical Technology.

On the Nature cover this week: Grow with the flow. Tissues ‘melt’ like glass to shape vertebrate embryos https://go.nature.com/2QLG4Av pic.twitter.com/9l11VhlTl0

On the Nature cover this week: Grow with the flow. Tissues ‘melt’ like glass to shape vertebrate embryos https://go.nature.com/2QLG4Av  pic.twitter.com/9l11VhlTl0

FDA encourages appropriate prescribing of opioids

The FDA has updated its Opioid Analgesic REMS to ensure caregivers and patients use opioids effectively... The post FDA encourages appropriate prescribing of opioids appeared first on European Pharmaceutical Review.

US FDA approves Opioid Analgesic REMS to encourage appropriate, rational prescribing of opioids

The US Food and Drug Administration (FDA) took new steps as part of its broader efforts to address the opioid crisis by approving the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS).

Chennai CWC likely to be dissolved, Selvakumar to become president of Chennai C&D

With the decision of the Tamil Nadu Chemists & Druggists Association (TNCDA) to give affiliation to the independently registered rebel group, Chennai Chemists & Druggists (Chennai C&D),

China’s world-leading stem-cell research continues to advance discovery. This Nature Collection showcases recent achievements, including the formation of blood stem cells at a single-cell level https://go.nature.com/2vX5pPj pic.twitter.com/ckZu2G1hlQ

China’s world-leading stem-cell research continues to advance discovery. This Nature Collection showcases recent achievements, including the formation of blood stem cells at a single-cell level https://go.nature.com/2vX5pPj  pic.twitter.com/ckZu2G1hlQ

Former Lululemon Executive Joins True Leaf as Chief Financial Officer

DGAP-News: True Leaf Medicine International Ltd. / Key word(s): Market launch/Change of Personnel 20.09.2018 / 13:10 The issuer is solely responsible for the content of this announcement. Former Lululemon Executive Joins True Leaf as Chief Financial Officer Kerry Biggs brings NASDAQ-level finance and operations experience at pivotal time in company's growth VERNON, BC - September 20, ...

It Starts with One

Every year around this time, we begin the process of putting together our educational program ...

Ridinilazole leading the way as Summit Therapeutics pivots to antibiotics

Following the disappointment of its DMD treatment over summer, Summit is leveraging its Discuva platform to develop new antibiotics, which doctors are in desperate need of

Managed access programmes offer an alternative way forward for drug companies

Eighteen of the top 20 big pharmaceutical companies now provide early access to their drugs

NetScientific rises as ProAxsis products selected for large-scale respiratory study

The BRIDGE study, funded by the European Respiratory Society, will be conducted over three years and involve 1,000 patients suffering from bronchiectasis across Europe

As demand for Internet and mobile-phone traffic skyrockets, the information industry could lead to an explosion in energy use. https://go.nature.com/2MvRSn9 

As demand for Internet and mobile-phone traffic skyrockets, the information industry could lead to an explosion in energy use. https://go.nature.com/2MvRSn9 

Epinephrine in Cardiac Arrest: Answers or Just More Questions?

Dr Amal Mattu asks the question: does a recent study in NEJM resolve the controversy on the use of epinephrine in out-of-hospital cardiac arrest? Medscape Emergency Medicine

Safety of Polymer-based Dental Fillings During Pregnancy

Endocrine disruptors can be released from polymer-based dental filling materials. Might their use present a risk to the fetus? BMC Oral Health

Estrogen-alone Therapy and Invasive Breast Cancer Incidence

Studies have demonstrated increased breast cancer risk associated with postmenopausal hormone therapy, but does risk vary depending on dose, formulation, and route of delivery of estrogen-alone HT? Menopause

Risk of NAFLD in Celiac Patients on a Gluten-free Diet

Does a gluten-free diet impact the risk of developing nonalcoholic fatty liver disease in patients with celiac disease? Alimentary Pharmacology & Therapeutics

Radiographs in Screening for Sacroiliitis in Children

This study examined the diagnostic utility of MRI and radiographs among children with suspected sacroiliitis. Arthritis Research & Therapy

Early Life Vitamin D Status and Asthma and Wheeze

A new study examines the possible effects of early life vitamin D levels on the development of asthma or wheeze later in life. BMC Pulmonary Medicine

Nontuberculous Mycobacteria in Cystic Fibrosis

In this article, the diagnosis, treatment, and impact of nontuberculous mycobacteria infection among patients with cystic fibrosis is discussed. Seminars in Respiratory and Critical Care Medicine

PPIs and Long-Term Risk of Pneumonia in Older Adults

Might long-term use of proton-pump inhibitors increase pneumonia risk in the elderly? Journal of the American Geriatrics Society

Hardman & Co Research: Oxford BioMedica (OXB): Partnering strategy delivering profitability

Hardman & Co Research 20-Sep-2018 / 10:55 GMT/BST Hardman & Co: Partnering strategy delivering profitability OXB is a specialist advanced therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, while retaining proprietary drug candidates. OXB will also receive royalties on commercial products developed with its LentiVector(R) platform....


Advertisement
Quick Search
Advertisement
Advertisement